National guidelines recommend that all pregnant women should be offered prenatal screening for fetal abnormalities with an emphasis on early, non-invasive testing options.
Verinata is developing simple, noninvasive alternatives to the invasive testing methods available today.
Translating unmet clinical needs into clinical utility that improves patient care and delivers uncompromising value to patients, clinicians and payers.
October 14, 2013
September 19, 2013
August 26, 2013